Cheaper, highly effective oral 'Ozempic' drugs are on the way
The race is on to develop the first daily weight-loss pill that would be both cheaper and less invasive than the current injectable drugs on the market, with the latest strong trial results from US company Terns following similarly positive outcomes from competitors including Eli Lilly, Roche and…| New Atlas
